Overall, our study adds to previous data showing upregulated SELENBP1 expression in schizophrenia; the consistency of this effect, together with mRNA being shown to be altered in blood as well as brain,1 indicates that it could be a candidate for inclusion in a panel of biomarkers that could be used to aid in diagnosis. This evidence concerns the gene SELENBP1 and schizophrenia.